Page last updated: 2024-09-04

abiraterone and sphingosine

abiraterone has been researched along with sphingosine in 1 studies

Compound Research Comparison

Studies
(abiraterone)
Trials
(abiraterone)
Recent Studies (post-2010)
(abiraterone)
Studies
(sphingosine)
Trials
(sphingosine)
Recent Studies (post-2010) (sphingosine)
942978548,3251173,459

Protein Interaction Comparison

ProteinTaxonomyabiraterone (IC50)sphingosine (IC50)
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)6.3125
cAMP-dependent protein kinase catalytic subunit alpha Rattus norvegicus (Norway rat)0.098
Sphingosine kinase 2Homo sapiens (human)1.56
Sphingosine kinase 1Homo sapiens (human)3.86

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Azad, AA; Bonnitcha, P; Briscoe, K; Butler, LM; Crumbaker, M; Davis, ID; Du, P; Fettke, H; Fitzpatrick, M; Horvath, LG; Huynh, K; Jia, S; Joshua, AM; Kwan, EM; Lin, HM; Mahon, KL; Mak, B; Marx, G; Meikle, PJ; Meikle, TG; Mellett, NA; Scheinberg, T; Stockler, MR; Stricker, PD; Sullivan, DR; Tran, B; Yeung, N; Yu, J; Zhang, A1

Other Studies

1 other study(ies) available for abiraterone and sphingosine

ArticleYear
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
    EBioMedicine, 2021, Volume: 72

    Topics: Aged; Aged, 80 and over; Androstenes; Benzamides; Biomarkers, Tumor; Cell Line, Tumor; Ceramides; Circulating Tumor DNA; Drug Resistance, Neoplasm; Humans; Lysophospholipids; Male; Nitriles; Phenylthiohydantoin; Phosphotransferases (Alcohol Group Acceptor); Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction; Sphingosine

2021